Literature DB >> 22033580

[Mild cognitive impairment in old age. Diagnostics and prognostic significance].

F M Reischies1, F Wertenauer.   

Abstract

Advances in clinical dementia research have made it possible to diagnose prodromal stages of various dementia syndromes. We present here the concept of mild cognitive impairment (MCI) as the most widely used concept for this stage of dementia processes. Necessary diagnostic procedures for MCI are presented, including clinical, neuropsychological and laboratory methods. Particularly in Alzheimer's disease it seems possible to diagnose a prodromal stage by using biomarkers and brain imaging, i.e. before the clinical dementia syndrome of the Alzheimer's type is present. When diagnosing dementia diseases in the stage of a clinical dementia syndrome, irreversible neuropathological processes are advanced. For this reason we should aim for the clinical detection of dementia disorders in the stage of mild cognitive impairment. This will lead to research on how to slow or even halt the progression of prodromal dementia.

Entities:  

Mesh:

Year:  2011        PMID: 22033580     DOI: 10.1007/s00115-011-3397-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  8 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

2.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

3.  Comorbidity of mild cognitive disorder and depression--a neuropsychological analysis.

Authors:  F M Reischies; P Neu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2000       Impact factor: 5.270

Review 4.  Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.

Authors:  B Winblad; K Palmer; M Kivipelto; V Jelic; L Fratiglioni; L-O Wahlund; A Nordberg; L Bäckman; M Albert; O Almkvist; H Arai; H Basun; K Blennow; M de Leon; C DeCarli; T Erkinjuntti; E Giacobini; C Graff; J Hardy; C Jack; A Jorm; K Ritchie; C van Duijn; P Visser; R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

Review 5.  Mild cognitive impairment: an overview.

Authors:  Ronald C Petersen; Selamawit Negash
Journal:  CNS Spectr       Date:  2008-01       Impact factor: 3.790

6.  Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.

Authors:  Oskar Hansson; Henrik Zetterberg; Peder Buchhave; Elisabet Londos; Kaj Blennow; Lennart Minthon
Journal:  Lancet Neurol       Date:  2006-03       Impact factor: 44.182

7.  [New perspectives in the laboratory diagnosis of dementia].

Authors:  M Bibl; J Wiltfang
Journal:  Nervenarzt       Date:  2008-11       Impact factor: 1.214

8.  Revising the definition of Alzheimer's disease: a new lexicon.

Authors:  Bruno Dubois; Howard H Feldman; Claudia Jacova; Jeffrey L Cummings; Steven T Dekosky; Pascale Barberger-Gateau; André Delacourte; Giovanni Frisoni; Nick C Fox; Douglas Galasko; Serge Gauthier; Harald Hampel; Gregory A Jicha; Kenichi Meguro; John O'Brien; Florence Pasquier; Philippe Robert; Martin Rossor; Steven Salloway; Marie Sarazin; Leonardo C de Souza; Yaakov Stern; Pieter J Visser; Philip Scheltens
Journal:  Lancet Neurol       Date:  2010-10-09       Impact factor: 44.182

  8 in total
  1 in total

1.  [Correlation of mental activity with cognitive functions  in mild cognitive impairment and early stage dementia].

Authors:  M Defrancesco; G Kemmler; R Huber; E A Deisenhammer
Journal:  Nervenarzt       Date:  2014-03       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.